Patents Assigned to Freie Universitaet Berlin
  • Publication number: 20150283094
    Abstract: A method for producing a polyglycerol nanogel is disclosed, the method comprising the following steps: Mixing an aqueous solution of first polyglycerol macromonomers, which are modified with a first reactive group, with an aqueous solution of second polyglycerol macromonomers, which are modified with a second reactive group, wherein the first reactive group and the second reactive group can react with each other forming a chemical bond; transferring the mixture into an organic non-solvent; and precipitation of a polyglycerol nanogel consisting of first polyglycerol macromonomers and second polyglycerol macromonomers which are covalently bound to each other. According to an aspect of the invention, the method is characterized in that the organic non-solvent is miscible with water and in that the method is carried out without adding surface-active substances.
    Type: Application
    Filed: September 5, 2013
    Publication date: October 8, 2015
    Applicant: FREIE UNIVERSITÄT BERLIN
    Inventors: Rainer Haag, Dirk Steinhilber, Wolfgang Friess, Sarah Hedtrich (Born Küchler), Madeleine Witting
  • Patent number: 9102595
    Abstract: The invention relates to a compound suited as entity carrier, having the general formula (I) wherein X is an amine-containing residue further defined herein. The invention further relates to the use of such compounds, a nanocarrier system, a kit comprising such compounds and methods for gene silencing and anti-cancer treatment.
    Type: Grant
    Filed: May 22, 2009
    Date of Patent: August 11, 2015
    Assignees: Ramot at Tel-Aviv University Ltd., Freie Universitaet Berlin
    Inventors: Rainer Haag, Wiebke Fischer, Mohiuddin Abdul Quadir, Ronit Satchi-Fainaro, Paula Ofek
  • Publication number: 20150010029
    Abstract: A laser pulse shaping method is configured for microscopically viewing and modifying an object. A temporal modulation and a two-dimensional spatial modulation of laser pulses are carried out. At least the phase of the laser pulses is modulated dependent on the location, and the modulated laser pulses are directed at the object.
    Type: Application
    Filed: January 17, 2013
    Publication date: January 8, 2015
    Applicant: FREIE UNIVERSITAET BERLIN
    Inventors: Albrecht Lindinger, Karsten Heyne
  • Patent number: 8920334
    Abstract: The invention relates to an analysis method for determining a functional parameter of an organ of a human or animal individual by measuring the 13CO2 content in the air exhaled by the individual to which a substrate has been administered the reaction of which in the body of the individual enriches the air exhaled by the individual with 13CO2. The method is characterized by using a measuring device, the maximum reaction rate of the substrate in the body of the individual being determined via a change of the measured 13CO2 content in the air exhaled by the individual using zero-order enzyme kinetics. The invention also relates to an aqueous methacetin solution for use in said analysis method, the pH of the solution being greater 7.0. The invention also relates to a face mask (1) for use in the inventive method for separating the exhaled air from the air inhaled by an individual. Said face mask comprises a face mask body (2) and an air cushion (3) encircling the face mask body.
    Type: Grant
    Filed: June 26, 2006
    Date of Patent: December 30, 2014
    Assignees: Freie Universitaet Berlin, Charité Universitaetmedizin Berlin
    Inventors: Martin Stockmann, Bjön Riecke
  • Patent number: 8809498
    Abstract: The invention relates to a compound having a structure according to the general formula P3-P2-P1-P1?-P2? (I), wherein residues P3, P2, P1, P1? and P2? are specifically defined and may be, e.g., certain amino acid residues. The invention further relates to the use of said compound and to a method for synthesizing a peptide.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: August 19, 2014
    Assignee: Freie Universitaet Berlin
    Inventors: Claudia Borelli, Hans Christian Korting, Elisabeth Ruge, Hans Dieter Hoeltje, Robert Huber, Beate Koksch, Cosimo Damiano Cadicamo
  • Publication number: 20140194549
    Abstract: A method for polymerizing monomer units and/or oligomer units is disclosed. Said method is characterized in that the energy required for polymerization is introduced into the monomer units and/or oligomer units to be polymerized by means of infrared light pulses, wherein the infrared light pulses have a wavelength of 2500 to 20000 nm, an intensity of more than 1014 W/m2, a duration of more than 8 fs and less than 3 ps and a substantially linear polarization.
    Type: Application
    Filed: June 6, 2012
    Publication date: July 10, 2014
    Applicant: FREIE UNIVERSITÄT BERLIN
    Inventors: Karsten Heyne, Anja Heyne
  • Patent number: 8575282
    Abstract: A modified compound that has at least one further functional group, in particular a bio- or macromolecule, comprising at least one x-fold (x?1) chemoselectively incorporated phosphoramidate group of general formula (I), NPO(OR1)(OR1?), and/or at least one x-fold (x?1) chemoselectively incorporated phosphonamide group of general formula (Ia), NPO(R1)(OR1?). R1 and R1? is selected from the group containing glycerol, polyglycerol, PEG polymers of the general empirical formula C2nH4n+2On+1 with n?1, Cn-alkyl chains with n?1; functionalized Cn-alkyl chains with n?1, aryls, heteroaryl, silyl, lipids, fluorophores, saccharides, peptides, crown ethers, or a linker, which links the aforementioned groups. R1 and R1? can be identical to or different from one another.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: November 5, 2013
    Assignee: Freie Universitaet Berlin
    Inventors: Christian Hackenberger, Giuseppe Del Signore, Remigiusz Serwa, Ina Wilkening, Robert Vallee
  • Publication number: 20130251747
    Abstract: The present invention provides compositions or vaccines that contain a recombinant EHV-1 that elicit an immune response in animals against equine herpesvirus, including compositions comprising said recombinant EHV-1, methods of vaccination against equine herpesvirus, and kits for use with such methods and compositions.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 26, 2013
    Applicants: FREIE UNIVERSITÄT BERLIN, MERIAL LIMITED
    Inventors: Jean Christophe Audonnet, Jules Maarten Minke, Nikolaus Osterrieder, Guanggang Ma
  • Publication number: 20130237591
    Abstract: The invention relates to the use of an L-ribozyme, which is capable of splitting an L-RNA in the region of a target sequence of the L-RNA, in order to produce a pharmaceutical composition for trating undesired physiological adverse reactions due to the administration of a therapeautic modecule containing the L-RNA. Alternatively, an endogeneous target RNA may also be split by the L-ribozyme.
    Type: Application
    Filed: March 28, 2013
    Publication date: September 12, 2013
    Applicant: Freie Universitaet Berlin
    Inventors: Volker A. Erdmann, Eliza Wyszko
  • Patent number: 8345718
    Abstract: A pulse shaper for compensating group runtime effects is provided. The pulse shaper comprising a first and a second dispersive element. An optical pulse can be coupled to the pulse shaper along a coupling direction such that said pulse exits from the pulse shaper after passing through the first and the second dispersive element along an exit direction. The first and the second dispersive element are formed and arranged to be movable relative to each other such that the path length to be traversed by the optical pulse through the first and the second dispersive element after coupling to the pulse shaper can be adjusted without any change in an offset between the coupling direction and the exit direction. The first and the second dispersive element are arranged in such a way that the shape of the optical pulse experiences a change as the pulse travels through the pulse shaper.
    Type: Grant
    Filed: May 6, 2009
    Date of Patent: January 1, 2013
    Assignee: Freie Universitaet Berlin
    Inventors: Karsten Heyne, Mathias Hartmann, Klaus Molkenthin
  • Publication number: 20120241622
    Abstract: A method for determining the 14C content of a gas mixture in which 14C isotopes are present as molecule constituents, is provided. The gas mixture is provided in a measuring space, wherein infrared laser radiation is supplied to the measuring space as measurement radiation. The laser radiation to be supplied to the measuring space is deflected such that it passes through the measuring space a plurality of times by interacting with the gas mixture, wherein the laser radiation is supplied to a detector, in order to determine the absorption of laser radiation by the gas mixture and therefrom determine the 14C content. For generating the laser radiation a pulsed laser is used, which as measurement radiation emits laser pulses with a pulse duration of less than 5 ?s, which are supplied to the measuring space.
    Type: Application
    Filed: August 27, 2010
    Publication date: September 27, 2012
    Applicant: FREIE UNIVERSITAET BERLIN
    Inventors: Karsten Heyne, Jens Beckmann, Tom Rubin
  • Publication number: 20120149763
    Abstract: The invention relates to the use of an L-ribozyme, which is capable of splitting an L-RNA in the region of a target sequence of the L-RNA, in order to produce a pharmaceutical composition for treating undesired physiological adverse reactions due to the administration of a therapeutic molecule containing the L-RNA. Alternatively, an endogenous target RNA may also be split by the L-ribozyme.
    Type: Application
    Filed: February 8, 2010
    Publication date: June 14, 2012
    Applicant: FREIE UNIVERSITAET BERLIN
    Inventors: Volker A. Erdmann, Eliza Wyszko
  • Publication number: 20120065344
    Abstract: A modified compound that has at least one further functional group, in particular a bio- or macromolecule, comprising at least one x-fold (x?1) chemoselectively incorporated phosphoramidate group of general formula (I), NPO(OR1) (OR1?), and/or at least one x-fold (x?1) chemoselectively incorporated phosphonamide group of general formula (Ia), NPO(R1)(OR1?). R1 and R1? is selected from the group containing glycerol, polyglycerol, PEG polymers of the general empirical formula C2nH4n+2On+1 with n?1, Cn-alkyl chains with n?1; functionalized Cn-alkyl chains with n?1, aryls, heteroaryl, silyl, lipids, fluorophores, saccharides, peptides, crown ethers, or a linker, which links the aforementioned groups. R1 and R1? can be identical to or different from one another.
    Type: Application
    Filed: March 9, 2010
    Publication date: March 15, 2012
    Applicant: FREIE UNIVERSITAET BERLIN
    Inventors: Christian Hackenberger, Giuseppe Del Signore, Remigiusz Serwa, Ina Wilkening, Robert Vallee
  • Publication number: 20120036242
    Abstract: A method for attribute selection for an event recognition in sensor networks is provided. The method comprising the following steps: in a configuration phase providing a quantity of attributes by sensor nodes of a sensor network, which characterize an event to be recognized, together with information on the topological origin of the attributes within the sensor network, and selecting a sub-quantity from the quantity of attributes, wherein the selection is made in consideration of the information on the topological origin of the attributes, and in an execution phase performing an event recognition for an event to be currently recognized on the basis of attributes which belong to a selected sub-quantity.
    Type: Application
    Filed: January 27, 2010
    Publication date: February 9, 2012
    Applicant: FREIE UNIVERSITAET BERLIN
    Inventors: Georg Wittenburg, Norman Dziengel, Christian Wartenburger
  • Publication number: 20120016103
    Abstract: The invention relates to a compound having a structure according to the general formula P3-P2-P1-P1?-P2? (I), wherein residues P3, P2, P1, P1? and P2? are specifically defined and may be, e.g., certain amino acid residues. The invention further relates to the use of said compound and to a method for synthesizing a peptide.
    Type: Application
    Filed: April 30, 2009
    Publication date: January 19, 2012
    Applicant: FREIE UNIVERSITAET BERLIN
    Inventors: Claudia Borelli, Hans Christian Korting, Elisabeth Ruge, Hans Dieter Hoeltje, Robert Huber, Beate Koksch, Cosimo Damiano Cadicamo
  • Patent number: 8097830
    Abstract: The invention relates to a method for material processing and/or material analysis of an object (18) made from condensed matter by means of a laser (12). A laser pulse (14) is generated by a laser, emitted in the direction of the object. The laser pulse is spatially and temporally focussed such as to give a peak power for the laser pulse at a point between the laser and the object which exceeds the critical power for a self-focussing effect of the laser pulse. The laser pulse thus forms a filament (88) of high power density. The filament (88) is directed at the object and generates an aggregation state change there (evaporation or plasma formation) for a part of the material of the object. The method can be applied to both material processing (cutting, drilling, welding, hardening) and material analysis (analysis of the plasma light).
    Type: Grant
    Filed: February 28, 2003
    Date of Patent: January 17, 2012
    Assignee: Freie Universitaet Berlin
    Inventors: Ludger Wöeste, Jean-Pierre Wolf
  • Publication number: 20110255563
    Abstract: A pulse shaper for compensating group runtime effects is provided. The pulse shaper comprising a first and a second dispersive element. An optical pulse can be coupled to the pulse shaper along a coupling direction such that said pulse exits from the pulse shaper after passing through the first and the second dispersive element along an exit direction. The first and the second dispersive element are formed and arranged to be movable relative to each other such that the path length to be traversed by the optical pulse through the first and the second dispersive element after coupling to the pulse shaper can be adjusted without any change in an offset between the coupling direction and the exit direction. The first and the second dispersive element are arranged in such a way that the shape of the optical pulse experiences a change as the pulse travels through the pulse shaper.
    Type: Application
    Filed: May 6, 2009
    Publication date: October 20, 2011
    Applicant: FREIE UNIVERSITAET BERLIN
    Inventors: Karsten Heyne, Mathias Hartmann, Klaus Molkenthin
  • Publication number: 20110182973
    Abstract: The invention relates to polymerase inhibitors, particularly polymerase alpha inhibitors, and the use thereof in the treatment of cell growth disorders, particularly tumor disorders, preferably actinic keratoses, basal cell carcinomas, and/or spinocellular carcinomas.
    Type: Application
    Filed: May 13, 2008
    Publication date: July 28, 2011
    Applicants: FREIE UNIVERSITAET BERLIN, HEINRICH-HEINE-UNIVERSITAET DUESSELDORF
    Inventors: Monika Schaefer-Korting, Hans-Dieter Hoeltje
  • Publication number: 20110117009
    Abstract: The present invention relates to a drug polymer conjugate comprising a pharmaceutically active compound and a dendritic polyglycerol, as well as to a drug polymer conjugate comprising a pharmaceutically and/or diagnostically active compound bound to a dendritic polyglycerol core having a polyethylene glycol shell.
    Type: Application
    Filed: March 31, 2009
    Publication date: May 19, 2011
    Applicants: FREIE UNIVERSITÄT BERLIN, KTB TUMORFORSCHUNGSGESELLSCHAFT MBH
    Inventors: Felix Kratz, Rainer Haag, Marcelo Calderon
  • Publication number: 20110045568
    Abstract: The invention relates to a method for restoring BMP-receptor signaling in a cell. According to the invention, the activity of the protein cGKI is increased in a cell. Furthermore, the invention relates to the use of cGKI for the treatment of a disease selected from the group consisting of pulmonary artery hypertension (PAH), cancer, fibrosis, bone diseases, and neurodegenerative diseases, and the use of cGKI for manufacturing a pharmaceutical composition for the treatment of said diseases, the use of a BMP receptor for screening for compounds having cGKI activity, the use of cGKI for screening for receptors associated with it, and the use of cGKI for the transcriptional activation of genes containing a BMP response element.
    Type: Application
    Filed: February 27, 2009
    Publication date: February 24, 2011
    Applicant: FREIE UNIVERSITÄT BERLIN
    Inventors: Petra Knaus, Raphaela Schwappacher